head and neck cancer

ESMO: Merck's Keytruda, alone and in combo, makes its case for earlier use in head and neck cancer
Fierce Pharma
Mon, 10/22/18 - 12:15 pm
Merck
head and neck cancer
Keytruda
Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market
CP Wire
Mon, 09/24/18 - 03:34 pm
Innovation Pharmaceuticals
severe oral mucositis
Brilacidin
head and neck cancer
Rakuten’s CEO raises $150M to fund his biotech outfit Aspyrian's cancer photoimmunotherapies
Fierce Biotech
Sat, 08/25/18 - 09:34 pm
Rakuten Aspyrian
photoimmunotherapy
head and neck cancer
CEL-SCI Gets Independent Recommendation to Continue PH III Head and Neck Cancer Trial
CP Wire
Wed, 08/15/18 - 09:45 am
Cel-Sci
Multikine
head and neck cancer
CEL-SCI Gets Independent Recommendation to Continue PH III Head and Neck Cancer Trial
Wed, 08/15/18 - 09:28 am
Cel-Sci
Multikine
head and neck cancer
Immunicum AB Announces FDA Approval to Expand Ph Ib/II trial of Cancer Drug
CP Wire
Mon, 07/23/18 - 10:12 am
Immunicum
clinical trials
ilixadencel
head and neck cancer
non-small cell lung cancer
gastric cancer
Seattle Genetics Doses First Patient In Ph II Trial of Antibody-drug Conjugate in Multiple Solid Tumors
CP Wire
Thu, 07/12/18 - 09:17 am
Seattle Genetics
colorectal cancer
non-small cell lung cancer
pancreatic cancer
head and neck cancer
cervical cancer
tisotumab vedotin
Genmab
clinical trials
Innovation Pharmaceuticals Reports on Successful Phase II Trial of Brilacidin-OM for Oral Mucositis
CP Wire
Mon, 04/9/18 - 03:39 pm
Innovation Pharmaceuticals
Brilacidin-OM
head and neck cancer
severe oral mucositis
On a new deal spree, Regeneron buys into ISA in pursuit of a checkpoint combo
Endpoints
Mon, 12/18/17 - 10:18 am
Regeneron
ISA
cervical cancer
head and neck cancer
cemiplimab
Can Pfizer Bank on New Immunotherapy Bavencio for Growth?
Yahoo/Zacks.com
Fri, 08/18/17 - 12:01 am
Pfizer
Bavencio
immuno-oncology
renal cell carcinoma
lung cancer
ovarian cancer
head and neck cancer
FDA gives OK, Cel-Sci clinical hold finally lifted
BioPharma Dive
Tue, 08/15/17 - 09:29 am
FDA
Cell-Sci
Multikine
clinical trials
head and neck cancer
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer
Xconomy
Tue, 07/25/17 - 12:06 am
Merck
Keytruda
head and neck cancer
Bristol-Myers' Opdivo racks up latest NICE rejection, this time in head and neck cancer
Fierce Pharma
Wed, 04/12/17 - 06:07 pm
Bristol-Myers Squibb
Opdivo
NICE
head and neck cancer
Bristol's Bid To Get Ahead In Head And Neck
Seeking Alpha
Tue, 11/15/16 - 09:17 am
Bristol-Myers Squibb
head and neck cancer
Opdivo
Keytruda
Merck
FDA slaps a partial hold on one of AstraZeneca’s crucial durvalumab programs
Endpoints
Fri, 10/28/16 - 10:12 am
FDA
AstraZeneca
durvalumab
clinical trials
head and neck cancer
How Pfizer Plans to Extend Ibrance beyond Breast Cancer Treatment
Market Realist
Fri, 09/2/16 - 11:24 am
Pfizer
Ibrance
breast cancer
head and neck cancer
lung cancer
pancreatic cancer
Bristol-Myers's Opdivo Extends Survival in Head, Neck Cancer
Bloomberg
Tue, 04/19/16 - 06:14 pm
Bristol-Myers Squibb
Opdivo
head and neck cancer
Keytruda, Opdivo near new cancer uses where they won't butt heads
Fierce Pharma
Fri, 04/15/16 - 08:39 am
Keytruda
Opdivo
Bristol-Myers Squibb
Merck
Hodgkin's lymphoma
head and neck cancer
Cel-Sci's Enrollment Math Doesn't Add up
TheStreet.com
Fri, 08/1/14 - 11:40 am
head and neck cancer
Cel-Sci
Multikine
First Presentation of Early Data for Pembrolizumab (MK-3475), Merck’s Investigational Anti-PD-1 Antibody, in Advanced Head and Neck Cancer at ASCO 2014
Yahoo/BusinessWire
Sun, 06/1/14 - 12:18 pm
Pembrolizumab
Merck
head and neck cancer

Pages